Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline
Jazz Pharmaceuticals to buy Chimerix for $935 million